https://exozymes.com/blog/2025-spartan-capital-confhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-29%20at%2022.14.43.pngScreenshot 2025-10-29 at 22.14.43Screenshot 2025-10-29 at 22.14.43https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-10-29https://exozymes.com/pipelinehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusiness-model-4business-model-4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/pharmaceuticals.svgpharmaceuticalspharmaceuticalshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/naturalproducts.svgnaturalproductsnaturalproductshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-02-06%20at%2014.33.52.pngScreenshot 2026-02-06 at 14.33.52Screenshot 2026-02-06 at 14.33.522026-02-20https://exozymes.com/blog/usa-today-caymanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogo_usatodaylogo_usatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-03-23https://exozymes.com/blog/process-development-engineerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/hiring.jpghiringhiringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-23https://exozymes.com/blog/nrel-doe-working-with-invizyne-in-their-advancing-clean-tech-to-energize-the-future-project-a-fireside-chathttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NREL.jpegNRELNRELhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/terms-of-usehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-07https://exozymes.com/blog/creating-value-for-partnershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-05%20at%2019.47.16%20(2).pngScreenshot 2025-02-05 at 19.47.16 (2)Screenshot 2025-02-05 at 19.47.16 (2)2026-02-17https://exozymes.com/blog/transcript-q4-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-01%20at%2013.50.47.pngScreenshot 2026-04-01 at 13.50.47Screenshot 2026-04-01 at 13.50.47https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/ladder17-podcast-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/D.%20Perriman.jpgD. PerrimanD. Perriman2026-06-29https://exozymes.com/blog/fundraise-closing-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-icon(fundraise).pngEXOZ-icon(fundraise)EXOZ-icon(fundraise)2026-06-17https://exozymes.com/blog/2026-mista-perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-12%20at%2023.00.10.pngScreenshot 2026-03-12 at 23.00.10Screenshot 2026-03-12 at 23.00.102026-04-20https://exozymes.com/blog/invizyne-technologies-begins-trading-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/invizynes-nasdaq-ipo-marks-new-era-of-biomanufacturinghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen_IPO%2Bnasdaq.pngHeltzen_IPO+nasdaqHeltzen_IPO+nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/new-ccohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien-(square-thumbnail).jpgDamien-(square-thumbnail)Damien-(square-thumbnail)2026-04-21https://exozymes.com/blog/podcast-the-catalyst-interviewhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Podcast%20Thumbnail_%20Michael%20Heltzen.pngPodcast Thumbnail_ Michael HeltzenPodcast Thumbnail_ Michael Heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/inside-biotech-podcasthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Square_Michael%20Heltzen.pngSquare_Michael HeltzenSquare_Michael Heltzen2026-04-20https://exozymes.com/sec-filingshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-06https://exozymes.com/blog/2025-mdb-capital-summithttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-12-21%20at%2023.59.16.pngScreenshot 2025-12-21 at 23.59.16Screenshot 2025-12-21 at 23.59.162025-12-21https://exozymes.com/blog/q1-2025nctxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx.pngQ1-earnings-call+NCTxQ1-earnings-call+NCTxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-12https://exozymes.com/blog/alphafold-to-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BAI.pngPaul+AIPaul+AIhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-05https://exozymes.com/blog/2025-beryl-elites-ai-panelhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Panel_Michael.jpgPanel_MichaelPanel_Michaelhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-12-15https://exozymes.com/blog/tyleramy2025-11-13https://exozymes.com/blog/2025-fast-companyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/20251121_FastCompany.jpg20251121_FastCompany20251121_FastCompanyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-12-16https://exozymes.com/blog/nct-breakthrough-paulhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BNCT(HD).jpgPaul+NCT(HD)Paul+NCT(HD)2026-04-21https://exozymes.com/blog/gen-biotechnology-coverstory2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GENBIO-cover.pngGENBIO-coverGENBIO-coverhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-05https://exozymes.com/blog/100x-scale-uphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_100xScaleUp.jpgEXOZ_100xScaleUpEXOZ_100xScaleUphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/nct-otchttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/peppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HD.mp4/medium.jpgpeppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HDpeppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/peppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HD.mp46nonohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/naturalproducts.svgnaturalproductsnaturalproductshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/HNF4%CE%B1.pngHNF4αHNF4α2026-02-18https://exozymes.com/blog/slack-capital-ceohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20Introduction%20(1).pngExoZymes - Introduction (1)ExoZymes - Introduction (1)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/partnershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/grow-your-biz.jpggrow your business with exozymesgrow-your-biz2026-02-06https://exozymes.com/privacy-policyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-07https://exozymes.com/blog/world-bio-market-insights-perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/WBMI-Retina.webpWBMI-RetinaWBMI-Retina2026-04-21https://exozymes.com/blog/biomass-magazine-enzymes-nlrhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-06-30%20at%2001.41.58.pngScreenshot 2026-06-30 at 01.41.58Screenshot 2026-06-30 at 01.41.582026-06-29https://exozymes.com/exozhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogo_usatodaylogo_usatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot 2026-03-25 at 13.11.59Screenshot 2026-03-25 at 13.11.59https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnail(investor)thumbnail(investor)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo(SoMe).pngeXoZ-logo(SoMe)eXoZ-logo(SoMe)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogo_businessinsiderlogo_businessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGEN2026-02-06https://exozymes.com/blog/nctx-launchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCTx_logo.pngNCTx_logoNCTx_logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-12https://exozymes.com/blog/firesidechat-part2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202024-12-31%20at%2001.05.49%20(2).pngScreenshot 2024-12-31 at 01.05.49 (2)Screenshot 2024-12-31 at 01.05.49 (2)2026-02-02https://exozymes.com/blog/business-insider-caymanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogo_businessinsiderlogo_businessinsider2026-03-23https://exozymes.com/blog/firesidechat-part4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-01-13%20at%2023.31.19%20(2).pngScreenshot 2025-01-13 at 23.31.19 (2)Screenshot 2025-01-13 at 23.31.19 (2)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/blog/big-skinny-basf-of-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-02-26%20at%2023.26.23.pngScreenshot 2026-02-26 at 23.26.23Screenshot 2026-02-26 at 23.26.23https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-27https://exozymes.com/blog/confcall2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-26%20at%2016.01.20%20(2).pngScreenshot 2025-03-26 at 16.01.20 (2)Screenshot 2025-03-26 at 16.01.20 (2)2026-04-01https://exozymes.com/blog/2025-q2-callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ%20Q2%20earnings%20call.pngeXoZ Q2 earnings calleXoZ Q2 earnings callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-08-07https://exozymes.com/blog/fox-business-basenesehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-17%20at%2015.57.12.pngScreenshot 2025-03-17 at 15.57.12Screenshot 2025-03-17 at 15.57.12https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-01https://exozymes.com/sec-filings-2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/hiring.jpghiringhiringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo-red.svgeXoZ-logo-redeXoZ-logo-redhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/bg_charcoal%2Btiffany.jpgbg_charcoal+tiffanybg_charcoal+tiffanyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/website-gfx/bg_dt-bridge.pngbg_dt-bridgebg_dt-bridgehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail-11.gifthumbnail-11thumbnail-11https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/website-gfx/hex_X.svghex_Xhex_Xhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/bg_dt-bridge(dark).jpgbg_dt-bridge(dark)bg_dt-bridge(dark)2025-02-12https://exozymes.com/blog/la-weekly-jbhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/LA_Weekly_logo.jpgLA_Weekly_logoLA_Weekly_logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/wbm25-panelhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-07-01%20at%2023.46.17.pngScreenshot 2025-07-01 at 23.46.17Screenshot 2025-07-01 at 23.46.17https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-21https://exozymes.com/blog/webull-biotech-sector-webinar-by-perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/banner.jpgbannerbanner2026-06-30https://exozymes.com/blog/bloomberg-kormanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-04-15%20at%2015.19.05.pngScreenshot 2025-04-15 at 15.19.05Screenshot 2025-04-15 at 15.19.05https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-12https://exozymes.com/blog/nlr-why-use-living-cellshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NLR.jpgNLRNLR2026-03-27https://exozymes.com/blog/synbiobeta2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/SBB.jpgSBBSBBhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-06https://exozymes.com/blog/2024-10khttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-26%20at%2016.01.20%20(2).pngScreenshot 2025-03-26 at 16.01.20 (2)Screenshot 2025-03-26 at 16.01.20 (2)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-02https://exozymes.com/blog/fox-business-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-13%20at%2021.45.28.pngScreenshot 2025-03-13 at 21.45.28Screenshot 2025-03-13 at 21.45.28https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-03-04https://exozymes.com/santalenehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/santalene.svgsantalenesantalenehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-06https://exozymes.com/blog/grant-cannabinoid-analogshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/$2MgrantNIH.png$2MgrantNIH$2MgrantNIH2026-06-24https://exozymes.com/blog/beryl-elites-interview-sanjeevhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-01-07%20at%2016.47.30.pngScreenshot 2026-01-07 at 16.47.30Screenshot 2026-01-07 at 16.47.30https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-01-08https://exozymes.com/nct-pharmahttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/glp1.svgglp1glp1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/MasterMetabolicSwitch.pngMasterMetabolicSwitchMasterMetabolicSwitch2026-02-06https://exozymes.com/blog/yahoo-finance-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_yahoo.svglogo_yahoologo_yahoohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-20https://exozymes.com/blog/a-cell-free-platform-for-the-prenylation-of-natural-products-and-application-to-cannabinoid-productionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot 2025-02-27 at 16.20.06Screenshot 2025-02-27 at 16.20.062026-02-02https://exozymes.com/blog/perriman-nasdaq-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien@Nasdaq(SoMe).jpgDamien@Nasdaq(SoMe)Damien@Nasdaq(SoMe)2026-04-20https://exozymes.com/blog/transcript-q2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/sc_team%2Bcall.pngsc_team+callsc_team+callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-08-13https://exozymes.com/blog/michael-burns-joins-invizyne-as-executive-vice-president-of-energy-transitionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/fuelpump.jpgfuelpumpfuelpump2026-02-02https://exozymes.com/blog/vanity-fair-ncthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Vanity_Fair.jpgVanity_FairVanity_Fair2026-04-20https://exozymes.com/blog/gcxn-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GCxN%2BEXOZ.jpgGCxN+EXOZGCxN+EXOZ2026-05-07https://exozymes.com/blog/exoz-ai-part1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail.pngthumbnailthumbnail2026-05-12https://exozymes.com/blog/transcript-4th-quarter-and-full-year-2024-from-april-2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-04-03%20at%2015.20.33.pngScreenshot 2025-04-03 at 15.20.33Screenshot 2025-04-03 at 15.20.33https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-06https://exozymes.com/blog/gen-march2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-03-23https://exozymes.com/blog/a-synthetic-biochemistry-module-for-production-of-bio-based-chemicals-from-glucosehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2016_naturechembio.png2016_naturechembio2016_naturechembio2026-02-02https://exozymes.com/blog/beryl-elites-interview-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-01-07%20at%2016.21.06.pngScreenshot 2026-01-07 at 16.21.06Screenshot 2026-01-07 at 16.21.06https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-01-07https://exozymes.com/blog/cayman-validation-investorshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnail(investor)thumbnail(investor)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/transcript-1st-quarter-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx-1.pngQ1-earnings-call+NCTx-1Q1-earnings-call+NCTx-12026-06-18https://exozymes.com/blog/a-molecular-rheostat-maintains-atp-levels-to-drive-a-synthetic-biochemistry-systemhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2017_naturechembio.jpeg2017_naturechembio2017_naturechembiohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/finding-genius-podcast-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-05-12%20at%2015.13.04.pngScreenshot 2026-05-12 at 15.13.04Screenshot 2026-05-12 at 15.13.042026-05-12https://exozymes.com/blog/mdb-capital-announces-record-date-and-expected-timing-for-initial-public-offering-for-invizyne-technologieshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/invizyne-technologies-expands-leadership-team-ahead-of-proposed-offering-and-listing-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen_IPO%2Bnasdaq.pngHeltzen_IPO+nasdaqHeltzen_IPO+nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/csohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-11-13%20at%2012.02.16.pngScreenshot 2025-11-13 at 12.02.16Screenshot 2025-11-13 at 12.02.162026-05-12https://exozymes.com/blog/nct-breakthrough-purityhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien%2BNCT(thumbnail).jpgDamien+NCT(thumbnail)Damien+NCT(thumbnail)2026-05-12https://exozymes.com/blog/nct-pilot-run-detailshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCT-for-testing(edit)NCT-for-testing(edit)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/scientisthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/hiring.jpghiringhiringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-23https://exozymes.com/blog/transcript-exoz-q3-2025-update2025-11-14https://exozymes.com/blog/invizyne-technologies-selected-for-2-million-project-to-advance-sustainable-aviation-fuel-capabilitieshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BioMADE%2BInvizyne.pngBioMADE+InvizyneBioMADE+Invizyne2026-02-02https://exozymes.com/blog/meta-pure-granthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul2.jpgPaul2Paul2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-06-26https://exozymes.com/partner-to-behttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-06https://exozymes.com/blog/a-synthetic-biochemistry-platform-for-cell-free-production-of-monoterpenes-from-glucosehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot 2025-02-27 at 16.20.06Screenshot 2025-02-27 at 16.20.06https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/invizyne-ipo-interview-with-dr.-james-j.-lalonde-by-mdb-capital-president-and-chief-market-strategist-lou-basenesehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_lalonde.jpgexo_lalondeexo_lalonde2026-02-02https://exozymes.com/blog/2025-podcast-lightning-rxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-12-17%20at%2014.32.50.pngScreenshot 2025-12-17 at 14.32.50Screenshot 2025-12-17 at 14.32.502026-04-20https://exozymes.com/blog/wtr-podcast-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/wtr-healthcarehappenings.jpgwtr-healthcarehappeningswtr-healthcarehappeningshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-06https://exozymes.com/signuphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot 2026-03-25 at 13.11.59Screenshot 2026-03-25 at 13.11.59https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogo_businessinsiderlogo_businessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogo_usatodaylogo_usatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnail(investor)thumbnail(investor)2026-02-06https://exozymes.com/blog/4q-2025-investorcallhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-29%20at%2019.10.02.pngScreenshot 2026-03-29 at 19.10.02Screenshot 2026-03-29 at 19.10.022026-04-01https://exozymes.com/blog/bionity-exoz-awarded-2m-granthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Bionity.pnglogo_Bionitylogo_Bionity2026-06-29https://exozymes.com/blog/a-synthetic-biochemistry-molecular-purge-valve-module-that-maintains-redox-balancehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot 2025-02-27 at 16.20.06Screenshot 2025-02-27 at 16.20.062026-02-02https://exozymes.com/blog/exozymes-pitchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen%2Bequation.jpgenzymes x AI = exozymesHeltzen+equationhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/blog/bio-innovations-midwest-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/54806567196_1c63f9d30b_k.jpg54806567196_1c63f9d30b_k54806567196_1c63f9d30b_khttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-10-08https://exozymes.com/blog/jane-king-interviews-ceo2025-11-12https://exozymes.com/blog/genesis-mission-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GenesisMissionGrant.jpgGenesisMissionGrantGenesisMissionGrant2026-07-23https://exozymes.com/blog/leadership-transition-rayohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_edgardo.jpgexo_edgardoexo_edgardohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-23https://exozymes.com/blog/exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo(SoMe)-1.pngeXoZ-logo(SoMe)-1eXoZ-logo(SoMe)-1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/abouthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A9143.jpg25_A914325_A9143https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8547.jpg25_A854725_A8547https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8557.jpg25_A855725_A8557https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnail(investor)thumbnail(investor)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8772-edited.jpg25_A8772-edited25_A8772-editedhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-12%20at%2023.00.10.pngScreenshot 2026-03-12 at 23.00.10Screenshot 2026-03-12 at 23.00.10https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8641.jpg25_A864125_A8641https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8526.jpg25_A852625_A8526https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8569%20(1).jpg25_A8569 (1)25_A8569 (1)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe).jpgthumbnail(SoMe)thumbnail(SoMe)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogo_usatodaylogo_usatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8604.jpg25_A860425_A8604https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8809.jpg25_A880925_A8809https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-TEAM.jpgEXOZ-TEAMEXOZ-TEAMhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot 2026-03-25 at 13.11.59Screenshot 2026-03-25 at 13.11.59https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogo_businessinsiderlogo_businessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8660.jpg25_A866025_A8660https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8726-edited.jpg25_A8726-edited25_A8726-editedhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8517.jpg25_A851725_A8517https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/James.jpgJamesJameshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8620-edited2.jpg25_A8620-edited225_A8620-edited22026-02-09https://exozymes.com/blog/nasdaq-closing-bell-ceremonyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/mc_021925_highres11.jpgmc_021925_highres11mc_021925_highres11https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-23https://exozymes.com/blog/slack-capital-chairmanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20MDB%20Capital%20(1).pngExoZymes - MDB Capital (1)ExoZymes - MDB Capital (1)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/blog/webulls-biotech-webinar-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/banner%202.jpgbanner 2banner 2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/blog/invizyne-technologies-announces-name-change-to-exozymes-inc.-and-new-ticker-symbolhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/post_image.jpgpost_imagepost_imagehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/blog/2025thinkequityconfhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-23%20at%2022.28.58.pngScreenshot 2025-10-23 at 22.28.58Screenshot 2025-10-23 at 22.28.582025-10-23https://exozymes.com/blog/slack-capital-vpofresearchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20Science%20(1).pngExoZymes - Science (1)ExoZymes - Science (1)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/blog/nasdaq-bell-ringinghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Nasdaq.jpgNasdaqNasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-23https://exozymes.com/blog/q1-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx-1.pngQ1-earnings-call+NCTx-1Q1-earnings-call+NCTx-1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/blog/a-bio-inspired-cell-free-system-for-cannabinoid-production-from-inexpensive-inputshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2020_naturechembio.jpeg2020_naturechembio2020_naturechembiohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/mdb-capital-ceo-and-invizyne-board-member-chris-marlett-presents-the-invizyne-story-and-initial-public-offering-ipo-opportunity-to-investors-via-zoom-on-june-11-2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_chris.jpgexo_chrisexo_chrishttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/synthetic-biochemistry-the-bio-inspired-cell-free-approach-to-commodity-chemical-productionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2020_cell.jpg2020_cell2020_cellhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/exoz-investor-pitch-may-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-05-11%20at%2023.13.21.pngScreenshot 2026-05-11 at 23.13.21Screenshot 2026-05-11 at 23.13.21https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-20https://exozymes.com/blog/q2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ%20Q2%20earnings%20call.pngeXoZ Q2 earnings calleXoZ Q2 earnings callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-09https://exozymes.com/blog/cayman-validationhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe).jpgthumbnail(SoMe)thumbnail(SoMe)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/with-nrels-help-gcxn-company-readies-for-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-10%20at%2000.15.01.pngScreenshot 2025-02-10 at 00.15.01Screenshot 2025-02-10 at 00.15.01https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/bioclickhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BioClick.jpgBioClickBioClick2026-05-12https://exozymes.com/technologyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul2.jpgPaul2Paul2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCT-for-testing(edit)NCT-for-testing(edit)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusiness-model-4business-model-4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail.pngthumbnailthumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BNCT(HD).jpgPaul+NCT(HD)Paul+NCT(HD)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien%2BNCT(thumbnail).jpgDamien+NCT(thumbnail)Damien+NCT(thumbnail)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_Perriman%2BOpgenorth.jpgEXOZ_Perriman+OpgenorthEXOZ_Perriman+Opgenorthhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/grow-your-biz(banner).jpggrow your business with exozymesgrow-your-biz(banner)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCTx_logo.pngNCTx_logoNCTx_logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BiochemistryWorkflow(eXoZ)-3.pngBiochemistryWorkflow(eXoZ)-3BiochemistryWorkflow(eXoZ)-32026-02-20https://exozymes.com/blog/2025berylelitesconfhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/1761745128907.jpeg176174512890717617451289072025-10-30https://exozymes.com/blog/announce-2025-3qt-earnings-call2025-11-10https://exozymes.com/blog/rolling-stone-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/RS_thumbnail.jpgRS_thumbnailRS_thumbnail2026-05-15https://exozymes.com/blog/upside-interview-episode2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Upside-thumbnail.pngUpside-thumbnailUpside-thumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/hiddenstockhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-05https://exozymes.com/blog/slack-capital-ccohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/_ExoZymes%20-%20Commercial%20(1).png_ExoZymes - Commercial (1)_ExoZymes - Commercial (1)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/blog/a-synthetic-biochemistry-system-for-the-in-vitro-production-of-isoprene-from-glycolysis-intermediateshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2014_proteinscience.jpg2014_proteinscience2014_proteinscience2026-02-02https://exozymes.com/blog/2025-ibt-exozhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/IBT.jpgIBTIBT2025-12-17https://exozymes.com/blog/refreshed-brand-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_logo(powered).pngEXOZ_logo(powered)EXOZ_logo(powered)2026-02-10https://exozymes.com/fcoihttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-07https://exozymes.com/blog/potential-impacthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-04%20at%2022.40.09%20(2)-1.pngScreenshot 2025-02-04 at 22.40.09 (2)-1Screenshot 2025-02-04 at 22.40.09 (2)-1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/blog/ceo-buys-iztc-stockhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)2026-02-02https://exozymes.com/blog/grow-everything-podcasthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail.jpgthumbnailthumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-18https://exozymes.com/investorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-01%20at%2013.50.47.pngScreenshot 2026-04-01 at 13.50.47Screenshot 2026-04-01 at 13.50.47https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_lonbell.jpgexo_lonbellexo_lonbellhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Anthony%20DiGiandomenico.webpAnthony DiGiandomenicoAnthony DiGiandomenicohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien@Nasdaq(SoMe).jpgDamien@Nasdaq(SoMe)Damien@Nasdaq(SoMe)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/James%20Bowie.jpgJames BowieJames Bowiehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Jim%20Lalonde%2c%20Ph.D..webpJim Lalonde, Ph.D.Jim Lalonde, Ph.D.https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_edgardo.jpgexo_edgardoexo_edgardohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Committee%20Composition%20(2700%20x%20675%20px).pngCommittee Composition (2700 x 675 px)Committee Composition (2700 x 675 px)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot 2026-03-25 at 13.11.59Screenshot 2026-03-25 at 13.11.59https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-05-11%20at%2023.13.21.pngScreenshot 2026-05-11 at 23.13.21Screenshot 2026-05-11 at 23.13.21https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-06%20at%2013.47.04%20(2).pngScreenshot 2025-10-06 at 13.47.04 (2)Screenshot 2025-10-06 at 13.47.04 (2)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusiness-model-4business-model-4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_chris.jpgexo_chrisexo_chrishttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-29%20at%2019.10.02.pngScreenshot 2026-03-29 at 19.10.02Screenshot 2026-03-29 at 19.10.022026-05-11https://exozymes.com/blog/once-in-a-lifetime-opportunity2025-11-19https://exozymes.com/blog/fundraise-pricing-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-icon(SoMe%2Bticker).pngEXOZ-icon(SoMe+ticker)EXOZ-icon(SoMe+ticker)2026-06-08https://exozymes.com/blog/4q-full-year-2025-callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot 2026-03-25 at 13.11.59Screenshot 2026-03-25 at 13.11.59https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-01https://exozymes.com/blog/gen-edge-whats-in-a-name-out-with-invizyne-in-with-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/What%E2%80%99s%20in%20a%20Name.pngWhat’s in a NameWhat’s in a Namehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-17https://exozymes.com/blog/ceo-michael-heltzen-and-co-founder-vp-of-research-dr.-tyler-korman-present-the-invizyne-story-and-ipo-opportunity-to-investorshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Michael%2BTyler.jpgCEO Michael Heltzen (left) and Tyler Korman, PhD, co-founder and VP of Research (right)Michael+Tylerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/biomade-thought-leadershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_Perriman%2BOpgenorth.jpgEXOZ_Perriman+OpgenorthEXOZ_Perriman+Opgenorth2026-04-21https://exozymes.com/blog/grow-everything-podcast-perriman-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe)-1.jpgthumbnail(SoMe)-1thumbnail(SoMe)-12026-04-20https://exozymes.com/blog/springwise-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/springwise.jpgspringwisespringwisehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/invizyne-technologies-announces-closing-of-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/blog/invizyne-technologies-announces-pricing-of-15-million-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.comhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Bloomberg.svglogo_Bloomberglogo_Bloomberghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_FoxBiz.svglogo_FoxBizlogo_FoxBizhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogo_businessinsiderlogo_businessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCT-for-testing(edit)NCT-for-testing(edit)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_LAweekly.svglogo_LAweeklylogo_LAweeklyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-TEAM.jpgEXOZ-TEAMEXOZ-TEAMhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogo_usatodaylogo_usatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_FastCo.svglogo_FastCologo_FastCohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/banner.jpgbannerbannerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_RS.svglogo_RSlogo_RShttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_yahoo.svglogo_yahoologo_yahoohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo-VillageVoice.svglogo-VillageVoicelogo-VillageVoicehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_ChemEng.svglogo_ChemEnglogo_ChemEnghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_WorldBioMarket.svglogo_WorldBioMarketlogo_WorldBioMarkethttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_VanityFair.svglogo_VanityFairlogo_VanityFairhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_logo(powered).pngEXOZ_logo(powered)EXOZ_logo(powered)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-06-30%20at%2001.41.58.pngScreenshot 2026-06-30 at 01.41.58Screenshot 2026-06-30 at 01.41.58https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_IBT.svglogo_IBTlogo_IBThttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Bionity.pnglogo_Bionitylogo_Bionityhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_GEN.svglogo_GENlogo_GENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Nasdaq.svglogo_Nasdaqlogo_Nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo-PRISM.pnglogo-PRISMlogo-PRISM2026-06-29https://exozymes.com/blog/gen-biotech-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GENbio_thumbnail(HD).pngGENbio_thumbnail(HD)GENbio_thumbnail(HD)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-12https://exozymes.com/bloghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-06-30%20at%2001.41.58.pngScreenshot 2026-06-30 at 01.41.58Screenshot 2026-06-30 at 01.41.58https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/D.%20Perriman.jpgD. PerrimanD. Perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Bionity.pnglogo_Bionitylogo_Bionityhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/banner%202.jpgbanner 2banner 2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-icon(fundraise).pngEXOZ-icon(fundraise)EXOZ-icon(fundraise)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/hiring.jpghiringhiringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/banner.jpgbannerbannerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/$2MgrantNIH.png$2MgrantNIH$2MgrantNIHhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo-PRISM.pnglogo-PRISMlogo-PRISM2026-02-06https://exozymes.com/blog/founder-storyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/tn_founding-eXoZ.pngtn_founding-eXoZtn_founding-eXoZ2026-02-02https://exozymes.com/blog/firesidechat-part1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202024-12-30%20at%2023.38.58%20(2).pngScreenshot 2024-12-30 at 23.38.58 (2)Screenshot 2024-12-30 at 23.38.58 (2)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02https://exozymes.com/cannabinoidshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/slow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HD.mp4/medium.jpgslow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HDslow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/slow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HD.mp414nonohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/pharmaceuticals-1.svgpharmaceuticals-1pharmaceuticals-1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-06https://exozymes.com/jobshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-03-04https://exozymes.com/blog/difference-between-enzymes-and-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-07%20at%2014.51.08%20(2).pngScreenshot 2025-02-07 at 14.51.08 (2)Screenshot 2025-02-07 at 14.51.08 (2)2026-02-17https://exozymes.com/blog/2025-3q-updatehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-11-13%20at%2012.35.54.pngScreenshot 2025-11-13 at 12.35.54Screenshot 2025-11-13 at 12.35.542026-02-09https://exozymes.com/blog/challenges-of-synbiohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-09-15%20at%2017.42.51%20(2).pngScreenshot 2025-09-15 at 17.42.51 (2)Screenshot 2025-09-15 at 17.42.51 (2)https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2025-09-15https://exozymes.com/blog/enzyme-break-outhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ChemEng.jpgChemEngChemEng2026-04-01https://exozymes.com/blog/podcast-genecoda-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-20%20at%2014.38.45.pngScreenshot 2026-04-20 at 14.38.45Screenshot 2026-04-20 at 14.38.452026-04-20https://exozymes.com/blog/nasdaq-interview-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail-11.gifthumbnail-11thumbnail-112026-02-06https://exozymes.com/blog/2026-village-voice-ncthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/villagevoice.jpgvillagevoicevillagevoicehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/firesidechat-part3https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-01-13%20at%2023.31.07%20(2).pngScreenshot 2025-01-13 at 23.31.07 (2)Screenshot 2025-01-13 at 23.31.07 (2)2026-02-02https://exozymes.com/blog/invizyne-technologies-to-begin-trading-on-nasdaq-on-november-13-2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)2026-02-02https://exozymes.com/blog/biotech-bulls-breakthroughs-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-13%20at%2019.38.41.pngScreenshot 2026-04-13 at 19.38.41Screenshot 2026-04-13 at 19.38.41https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-04-20https://exozymes.com/blog/invizyne-awarded-additional-3.77-million-grant-from-u.s.-department-of-energyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-05-05https://exozymes.com/blog/prism-exoz-push-into-cannabinoidshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo-PRISM.pnglogo-PRISMlogo-PRISMhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-06-29https://exozymes.com/blog/commercializing-invizynes-cell-free-platform-fireside-chat-with-zachary-karl-phd-vp-of-bizdev-and-lou-basenese-president-chief-market-strategist-at-mdb-capitalhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_zach.jpgZachary Karl, PhD, VP of Business Developmentexo_zach2026-02-02https://exozymes.com/blog/invizyne-technologies-announces-filing-of-registration-statement-for-proposed-offering-and-listing-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyne Technologies, Inc.invizyne-logo(sq)2026-02-02https://exozymes.com/blog/invizyne-selected-by-shell-gamechanger-accelerator-powered-by-nrel-for-sixth-cohorthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymes-logoeXoZymes-logo2026-02-02